Dual ctDNA and CTCs analysis for minimal residual disease detection and relapse monitoring in early-stage breast cancer.
- DOI
- 10.1038/s41523-026-00970-9
- Published
- 2026 May 20
- Container
- NPJ breast cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41523-026-00970-9,
title = {Dual ctDNA and CTCs analysis for minimal residual disease detection and relapse monitoring in early-stage breast cancer.},
author = {Velasco-Suelto J and Quirós-Ortega ME and Pascual J and Godoy-Ortiz A and Alba-Bernal A and López-López E and Domínguez-Recio ME and Jiménez-Rodríguez B and Peralta-Linero J and Bellagarza-García E and Troyano-Ramos L and Garrido-Ruiz G and Hierro-Martín MI and Ortega MV and Garrido-Aranda A and Lavado-Valenzuela R and Álvarez M and Alba E and Comino-Méndez I},
year = {2026},
journal = {NPJ breast cancer},
doi = {10.1038/s41523-026-00970-9},
url = {https://doi.org/10.1038/s41523-026-00970-9}
}RIS
TY - JOUR TI - Dual ctDNA and CTCs analysis for minimal residual disease detection and relapse monitoring in early-stage breast cancer. AU - Velasco-Suelto J AU - Quirós-Ortega ME AU - Pascual J AU - Godoy-Ortiz A AU - Alba-Bernal A AU - López-López E AU - Domínguez-Recio ME AU - Jiménez-Rodríguez B AU - Peralta-Linero J AU - Bellagarza-García E AU - Troyano-Ramos L AU - Garrido-Ruiz G AU - Hierro-Martín MI AU - Ortega MV AU - Garrido-Aranda A AU - Lavado-Valenzuela R AU - Álvarez M AU - Alba E AU - Comino-Méndez I PY - 2026 JO - NPJ breast cancer DO - 10.1038/s41523-026-00970-9 UR - https://doi.org/10.1038/s41523-026-00970-9 ER -
APA
J, V., ME, Q., J, P., A, G., A, A., E, L., ME, D., B, J., J, P., E, B., L, T., G, G., MI, H., MV, O., A, G., R, L., M, Á., E, A., & I, C. (2026). Dual ctDNA and CTCs analysis for minimal residual disease detection and relapse monitoring in early-stage breast cancer.. NPJ breast cancer. https://doi.org/10.1038/s41523-026-00970-9
Source records
- pubmed · retrieved 2026-09-26T04:44:46.383Z